4//SEC Filing
Bligh James 4
Accession 0001493152-23-043745
CIK 0001896212other
Filed
Dec 4, 7:00 PM ET
Accepted
Dec 5, 5:20 PM ET
Size
5.5 KB
Accession
0001493152-23-043745
Insider Transaction Report
Form 4
Bligh James
DirectorCFO
Transactions
- Award
Stock Option (Right to Buy)
2023-12-01$5.51/sh+223,634$1,232,223→ 223,634 totalExercise: $5.51Exp: 2033-11-30→ Common Stock (223,634 underlying)
Footnotes (2)
- [F1]Represents Options to purchase common stock, granted under the Company's 2023 Stock Incentive Plan.
- [F2]The stock options were granted with a ten-year term and vest 25% on each of the first four anniversaries of the vesting commencement date, which is September 22, 2023.
Documents
Issuer
CONDUIT PHARMACEUTICALS INC.
CIK 0001896212
Entity typeother
Related Parties
1- filerCIK 0001990748
Filing Metadata
- Form type
- 4
- Filed
- Dec 4, 7:00 PM ET
- Accepted
- Dec 5, 5:20 PM ET
- Size
- 5.5 KB